Colonic polyps — post-polypectomy surveillance
Polyp surveillance · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
After complete adenoma/serrated polyp removal, risk-stratified colonoscopic surveillance targets patients with high-risk findings, while most low-risk patients return to routine screening — reducing unnecessary colonoscopy.
Red flags
- Malignant polyp with adverse histology
- Incomplete resection of a large lesion
- Large serrated lesion or serrated polyposis
- Poor bowel prep limiting detection (repeat sooner)
Assessment
Differential diagnosis
- Adenomatous polyps (tubular, tubulovillous, villous)
- Serrated lesions (sessile serrated lesion, traditional serrated adenoma, hyperplastic)
- Malignant polyp (invasive)
- Inflammatory/pseudopolyps
- Hereditary polyposis syndrome
Investigations
- Complete colonoscopy with removal and retrieval of all polyps
- Histology of all resected lesions (size, number, dysplasia, villous/serrated features)
- Documentation of completeness of resection and bowel prep quality
- Consider genetics referral if numerous polyps or young age
- CT colonography if colonoscopy incomplete
Management
- Ensure complete, high-quality index colonoscopy with adequate preparation and caecal intubation
- Resect and retrieve all polyps for histology
- Classify findings by number, size (≥10 mm), and high-risk histology (villous, high-grade dysplasia, serrated)
- Define high-risk: ≥2 premalignant polyps including an advanced one, or ≥5 premalignant polyps
- Offer a surveillance colonoscopy (e.g. at 3 years) to high-risk patients
- Return low-risk patients to routine (FIT) screening rather than short-interval colonoscopy
- Arrange earlier repeat if index examination incomplete or piecemeal resection of a large lesion
- Perform site check/repeat for large (≥20 mm) piecemeal endoscopic resections at 2–6 months
- Refer malignant polyps with adverse features for MDT/surgical discussion
- Consider polyposis syndromes if polyp burden is high or patient is young
- Document the agreed surveillance plan and recall clearly
Drugs & doses
No specific pharmacotherapy — surveillance is endoscopic
Bowel preparation for colonoscopy (e.g. macrogol-based)
Disposition
Endoscopy surveillance register with clear recall; MDT for malignant polyps.
Complications & pitfalls
- Interval cancer (missed/inadequately resected lesions)
- Post-polypectomy bleeding or perforation
- Over-surveillance (procedural risk, cost)
- Recurrence at large resection sites
Exam pearls
- Most patients after polypectomy do NOT need short-interval colonoscopy — return low-risk cases to routine screening
- High-risk findings (advanced adenoma, multiple polyps) drive the need for 3-year surveillance
- Large piecemeal resection sites need an early (2–6 month) site check
- Quality of the index colonoscopy (prep, caecal intubation, complete resection) determines surveillance reliability
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.